View in EDS

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

Saved in:
Bibliographic Details
Title: Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Authors: Lee J (AUTHOR), Park SH (AUTHOR), Chang HM (AUTHOR), Kim JS (AUTHOR), Choi HJ (AUTHOR), Lee MA (AUTHOR), Chang JS (AUTHOR), Jeung HC (AUTHOR), Kang JH (AUTHOR), Lee HW (AUTHOR), Shin DB (AUTHOR), Kang HJ (AUTHOR), Sun JM (AUTHOR), Park JO (AUTHOR), Park YS (AUTHOR), Kang WK (AUTHOR), Lim HY (AUTHOR)
Source: Lancet Oncology. Feb2012, Vol. 13 Issue 2, p181-188. 8p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 104512265
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lee+J%22">Lee J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park+SH%22">Park SH</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang+HM%22">Chang HM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim+JS%22">Kim JS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choi+HJ%22">Choi HJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee+MA%22">Lee MA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang+JS%22">Chang JS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jeung+HC%22">Jeung HC</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang+JH%22">Kang JH</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee+HW%22">Lee HW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shin+DB%22">Shin DB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang+HJ%22">Kang HJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun+JM%22">Sun JM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park+JO%22">Park JO</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park+YS%22">Park YS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang+WK%22">Kang WK</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim+HY%22">Lim HY</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Feb2012, Vol. 13 Issue 2, p181-188. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=104512265
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 181
    Titles:
      – TitleFull: Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Park SH
      – PersonEntity:
          Name:
            NameFull: Chang HM
      – PersonEntity:
          Name:
            NameFull: Kim JS
      – PersonEntity:
          Name:
            NameFull: Choi HJ
      – PersonEntity:
          Name:
            NameFull: Lee MA
      – PersonEntity:
          Name:
            NameFull: Chang JS
      – PersonEntity:
          Name:
            NameFull: Jeung HC
      – PersonEntity:
          Name:
            NameFull: Kang JH
      – PersonEntity:
          Name:
            NameFull: Lee HW
      – PersonEntity:
          Name:
            NameFull: Shin DB
      – PersonEntity:
          Name:
            NameFull: Kang HJ
      – PersonEntity:
          Name:
            NameFull: Sun JM
      – PersonEntity:
          Name:
            NameFull: Park JO
      – PersonEntity:
          Name:
            NameFull: Park YS
      – PersonEntity:
          Name:
            NameFull: Kang WK
      – PersonEntity:
          Name:
            NameFull: Lim HY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1